3 Adhesives and Construction Chemicals Company, Pharmaceutical Formulations Maker and Hotel Chain Stocks With a Strong Future Roadmap: Pidilite Industries, Lincoln Pharmaceuticals and Lemon Tree Hotels
- November 6, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Pidilite Industries, Lincoln Pharmaceuticals and Lemon Tree Hotels: ROE of 11.6% to 22.6% and FY22 to FY26 revenue CAGR of 9.9% to 37.7%. Prices as of 5 Nov 2026.
Quick Answer
The three adhesive, formulations and budget hotel stocks to watch are Pidilite Industries, Lincoln Pharmaceuticals and Lemon Tree Hotels. Their return on equity ranges from 11.6% to 22.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.9% to 37.7%. Pidilite Industries has the highest return on equity at 22.6%, while Lemon Tree Hotels has the fastest revenue growth at 37.7% a year. Prices are based on the 5 November 2026 close, and this article is educational, not investment advice.
Adhesive, formulations and budget hotel stocks give investors a way to track businesses that sit close to everyday demand in India. Pidilite Industries, Lincoln Pharmaceuticals and Lemon Tree Hotels cover an adhesives and construction chemicals company, a pharmaceutical formulations maker and a hotel chain.
This list covers three adhesive, formulations and budget hotel stocks with complete current figures: Pidilite Industries, Lincoln Pharmaceuticals and Lemon Tree Hotels. Every figure comes from the latest reported financials and the 5 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Adhesive, Formulations and Budget Hotel Stocks?
Adhesive, formulations and budget hotel stocks are listed companies that make adhesives, sealants and construction chemicals, produce and sell pharmaceutical formulations, and operate hotels across budget and mid-priced segments. Their earnings depend on housing and repair demand, medicine sales and room occupancy.
Adhesive, Formulations and Budget Hotel Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Pidilite Industries | 1,553.6 | 150,953 | 56.4 | 35.1 | 22.6 | 0.04 |
| Lincoln Pharmaceuticals | 512.55 | 1,067 | 11.1 | 36.0 | 11.6 | 0.01 |
| Lemon Tree Hotels | 117.53 | 8,849 | 29.7 | 37.9 | 16.3 | 1.44 |
On valuation, Lincoln Pharmaceuticals and Lemon Tree Hotels trade at a P/E below the industry P/E, while Pidilite Industries trades above it, which reflects the growth the market already expects. Readers comparing adhesive, formulations and budget hotel stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in adhesive, formulations and budget hotel stocks can use the coming numbers to test whether growth is holding.
Why Do Adhesive, Formulations and Budget Hotel Stocks Have a Strong Roadmap in India?
Adhesive, formulations and budget hotel stocks have a strong roadmap in India because rising housing and renovation work, steady demand for affordable medicines and growing domestic travel keep widening the market for these companies.
- Adhesives. Homes and factories use more bonding products.
- Pharma. Affordable medicines reach more patients.
- Hotels. Domestic travel fills mid-priced rooms.
Why Pidilite Industries Features Among These Adhesive, Formulations and Budget Hotel Stocks
Among the adhesive, formulations and budget hotel stocks on this list, Pidilite Industries is India’s leading adhesives and construction chemicals company and the maker of Fevicol, Dr. Fixit, M-Seal and Fevikwik, among other brands.
In the June 2026 quarter, revenue grew 21.0% year on year to Rs 4,644 crore, while net profit rose 30.3% to Rs 884 crore. Revenue rose from Rs 9,957 crore in FY22 to Rs 14,867 crore in FY26, a compound annual growth rate of 10.5%.
Net profit grew from Rs 1,207 crore in FY22 to Rs 2,471 crore in FY26, which works out to a compound annual growth rate of 19.6%. The company has a return on equity of 22.6%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 150,953 crore. The stock trades at a P/E of 56.4, above the industry P/E of 35.1.
Roadmap: The company has a strong brand and a vast distribution network, and it continues to add products in waterproofing, paints and construction chemicals. Premium categories and new launches contribute to growth in housing and renovation.
What to watch: Check volume growth in consumer and bazaar products and the trend in raw material prices.
Why Lincoln Pharmaceuticals Features Among These Adhesive, Formulations and Budget Hotel Stocks
Among the glue, medicine and stay shares on this list, Lincoln Pharmaceuticals is an Ahmedabad-based maker of branded generics and formulations in India and exports to emerging markets, with products across anti-infectives, respiratory and pain care.
The company has a return on equity of 11.6%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 1,067 crore. The stock trades at a P/E of 11.1, below the industry P/E of 36.0.
Revenue rose from Rs 482 crore in FY22 to Rs 704 crore in FY26, a compound annual growth rate of 9.9%. Net profit grew from Rs 69.4 crore in FY22 to Rs 87.9 crore in FY26, which works out to a compound annual growth rate of 6.1%. In the June 2026 quarter, revenue grew 19.0% year on year to Rs 202 crore, while net profit rose 30.9% to Rs 36.2 crore.
Roadmap: The company is expanding its branded portfolio and export markets while adding new products. A focus on emerging markets spreads revenue across regions.
What to watch: Track branded product growth, export orders and new launches.
Why Lemon Tree Hotels Features Among These Adhesive, Formulations and Budget Hotel Stocks
Among the three companies on this list, Lemon Tree Hotels is one of India’s largest mid-priced hotel chains, operating and managing hotels under the Lemon Tree, Red Fox, Aurika and Keys brands.
Revenue rose from Rs 408 crore in FY22 to Rs 1,465 crore in FY26, a compound annual growth rate of 37.7%. Net profit grew from Rs 141 crore in FY23 to Rs 288 crore in FY26, which works out to a compound annual growth rate of 27.1%.
In the June 2026 quarter, revenue grew 9.2% year on year to Rs 347 crore, while net profit rose 19.2% to Rs 57.3 crore. The company has a return on equity of 16.3%, a debt to equity ratio of 1.44 and a market capitalisation of Rs 8,849 crore. The stock trades at a P/E of 29.7, below the industry P/E of 37.9.
Roadmap: The company is adding rooms mainly through management contracts, which grow its footprint with limited capital outlay. Rising domestic travel and a focus on the mid-priced segment support healthy occupancy.
What to watch: Monitor new room signings and openings and average room rate trends.
Pidilite Industries vs Lincoln Pharmaceuticals vs Lemon Tree Hotels on Key Financials
The table below sets the three adhesive, formulations and budget hotel stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Pidilite Industries | 9,957 | 14,867 | 10.5% | 2,471 | 16.6% |
| Lincoln Pharmaceuticals | 482 | 704 | 9.9% | 87.9 | 12.5% |
| Lemon Tree Hotels | 408 | 1,465 | 37.7% | 288 | 19.7% |
Pidilite Industries posts the highest return on equity in this group at 22.6%. Pidilite Industries has the largest FY26 revenue at Rs 14,867 crore, and Lemon Tree Hotels shows the fastest revenue growth with a 37.7% compound annual rate. A useful habit with adhesive, formulations and budget hotel stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Pidilite Industries | 3,839 | 4,644 | 21.0% |
| Lincoln Pharmaceuticals | 169 | 202 | 19.0% |
| Lemon Tree Hotels | 317 | 347 | 9.2% |
Key Risks to Check Before Investing in Adhesive, Formulations and Budget Hotel Stocks
Every theme carries risks that deserve a check before any decision. For these adhesive, formulations and budget hotel stocks, the main points are: Long-term glue, medicine and stay shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Raw material costs. Ingredient and packaging prices can move margins.
- Travel cycles. Bookings and occupancy follow travel demand.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter adhesive, formulations and budget hotel stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Adhesive, Formulations and Budget Hotel Stocks
Adhesive, formulations and budget hotel stocks work best when investors track growth, valuation and return on equity side by side. Pidilite Industries, Lincoln Pharmaceuticals and Lemon Tree Hotels each have a clear plan to grow. Based on the 5 November 2026 close, Pidilite Industries trades at Rs 1,553.6, Lincoln Pharmaceuticals at Rs 512.55 and Lemon Tree Hotels at Rs 117.53. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these adhesive, formulations and budget hotel stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track adhesive, formulations and budget hotel stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are adhesive, formulations and budget hotel stocks?
Ans. Adhesive, formulations and budget hotel stocks are listed companies that make adhesives, sealants and construction chemicals, produce and sell pharmaceutical formulations, and operate hotels across budget and mid-priced segments. Their earnings depend on housing and repair demand, medicine sales and room occupancy. This list looks at three of them, Pidilite Industries, Lincoln Pharmaceuticals and Lemon Tree Hotels, using reported FY22 to FY26 financials and the 5 November 2026 closing prices.
Which adhesive, formulations and budget hotel stocks are covered in this list?
Ans. This list covers Pidilite Industries, Lincoln Pharmaceuticals and Lemon Tree Hotels. Based on the 5 November 2026 close, Pidilite Industries traded at Rs 1,553.6, Lincoln Pharmaceuticals at Rs 512.55 and Lemon Tree Hotels at Rs 117.53. Their return on equity ranges from 11.6% to 22.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.9% to 37.7%.
Why do adhesive, formulations and budget hotel stocks have a strong future roadmap in India?
Ans. Adhesive, formulations and budget hotel stocks have a strong roadmap in India because rising housing and renovation work, steady demand for affordable medicines and growing domestic travel keep widening the market for these companies. The main drivers are as follows. Adhesives. Homes and factories use more bonding products. Pharma. Affordable medicines reach more patients. Hotels. Domestic travel fills mid-priced rooms. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Pidilite Industries performed financially?
Ans. Revenue rose from Rs 9,957 crore in FY22 to Rs 14,867 crore in FY26, a compound annual growth rate of 10.5%. Net profit grew from Rs 1,207 crore in FY22 to Rs 2,471 crore in FY26, which works out to a compound annual growth rate of 19.6%. In the June 2026 quarter, revenue grew 21.0% year on year to Rs 4,644 crore, while net profit rose 30.3% to Rs 884 crore. The company has a return on equity of 22.6%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 150,953 crore. The stock trades at a P/E of 56.4, above the industry P/E of 35.1. Looking ahead, the company has a strong brand and a vast distribution network, and it continues to add products in waterproofing, paints and construction chemicals. Premium categories and new launches contribute to growth in housing and renovation.
How has Lincoln Pharmaceuticals performed financially?
Ans. Revenue rose from Rs 482 crore in FY22 to Rs 704 crore in FY26, a compound annual growth rate of 9.9%. Net profit grew from Rs 69.4 crore in FY22 to Rs 87.9 crore in FY26, which works out to a compound annual growth rate of 6.1%. In the June 2026 quarter, revenue grew 19.0% year on year to Rs 202 crore, while net profit rose 30.9% to Rs 36.2 crore. The company has a return on equity of 11.6%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 1,067 crore. The stock trades at a P/E of 11.1, below the industry P/E of 36.0. Looking ahead, the company is expanding its branded portfolio and export markets while adding new products. A focus on emerging markets spreads revenue across regions.
How has Lemon Tree Hotels performed financially?
Ans. Revenue rose from Rs 408 crore in FY22 to Rs 1,465 crore in FY26, a compound annual growth rate of 37.7%. Net profit grew from Rs 141 crore in FY23 to Rs 288 crore in FY26, which works out to a compound annual growth rate of 27.1%. In the June 2026 quarter, revenue grew 9.2% year on year to Rs 347 crore, while net profit rose 19.2% to Rs 57.3 crore. The company has a return on equity of 16.3%, a debt to equity ratio of 1.44 and a market capitalisation of Rs 8,849 crore. The stock trades at a P/E of 29.7, below the industry P/E of 37.9. Looking ahead, the company is adding rooms mainly through management contracts, which grow its footprint with limited capital outlay. Rising domestic travel and a focus on the mid-priced segment support healthy occupancy.
What risks should investors check before buying adhesive, formulations and budget hotel stocks?
Ans. Investors should check a few risks before buying adhesive, formulations and budget hotel stocks. Raw material costs. Ingredient and packaging prices can move margins. Travel cycles. Bookings and occupancy follow travel demand. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of adhesive, formulations and budget hotel stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 5 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.